Rubicon Research Ltd
Q1 FY27, unaudited
- Revenue
- ₹427.73 Cr
- Profit after tax
- ₹82.45 Cr
As filed with the exchange, standalone basis.
Statement of profit and loss
Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.
| ₹ crore | Q1 FY27 | vs a year ago | FY26 |
|---|---|---|---|
| Revenue from operations | 427.73 | — | 1,306.08 |
| Other income | 2.41 | — | 10.83 |
| Total income | 430.14 | — | 1,316.91 |
| Employee benefit expense | 51.52 | — | 164.27 |
| Finance costs | 6.01 | — | 30.96 |
| Depreciation & amortisation | 10.57 | — | 37.75 |
| Total expenses | 319.48 | — | 1,064.14 |
| Profit before tax | 110.66 | — | 252.78 |
| Tax expense | 28.21 | — | 64.61 |
| Profit after tax | 82.45 | — | 188.17 |
| Total comprehensive income | 82.50 | — | 187.37 |
| Earnings per share, basic | ₹4.99 | ₹11.83 |
|---|---|---|
| Earnings per share, diluted | ₹4.94 | ₹11.67 |
Q1 FY27 — unaudited, from the company’s filing with NSE. Source
FY26 — from the company’s filing with NSE. Source
Why the dash
Parakho has not ingested this company’s year-ago quarter, so the change column stays empty. A dash means we do not hold the figure — never that it is zero.
Earnings call
Q4 FY26Rubicon Research reported Q4 FY26 revenue of INR5,139-5,140 million, up 44% year-on-year, with EBITDA of INR1,190-1,213 million and PAT growth of 111-112% for the quarter. Management attributed growth to broad-based demand across established products and new launches, and described a slight decline in gross margin due to increased reliance on outsourced manufacturing while the Pithampur facility awaits FDA inspection. The company also disclosed the acquisition of an 85% stake in Arinna Lifesciences to build a CNS platform in the Indian market, and the board recommended a dividend of 150% (INR1.5 per share).
Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary
Filings
12 shown · 47 published by the exchange
19 Aug 2026
Transcript15 Aug 2026
Filing14 Aug 2026
14 Aug 2026
Filing14 Aug 2026
Filing14 Aug 2026
Presentation14 Aug 2026
13 Aug 2026
11 Aug 2026
07 Aug 2026
Concall07 Aug 2026
04 Aug 2026
Filing
BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.
Page generated from filings held to 19 Aug 2026.